The Durvalumab Market: Key Developments and Future Insights
The Durvalumab market continues to gain momentum as advancements in immunotherapy reshape cancer treatment paradigms. Durvalumab, a PD-L1 inhibitor developed by AstraZeneca, has been a cornerstone in the fight against … Read More